Natura &Co Decides to Delist from NYSE

Beauty conglomerate Natura &Co has unveiled its decision to delist from the New York Stock Exchange (NYSE) as part of an ongoing strategy focused on “simplifying operations.”

The company’s board outlined this move in a regulatory filing, emphasizing its intent to maintain its primary listing of common shares on the B3 stock exchange in São Paulo, Brazil, where its roots lie.

Citing a “decreasing trading volume” of shares in New York, the board deemed the listing there no longer a “compelling option,” driving the decision.

The suspension of shares is anticipated to occur on or around February 9, 2024.

CEO Fabio Barbosa, in the filing, stated, “The planned delisting of Natura &Co from the NYSE is consistent with our long-term strategy for the business. This move underscores our continued focus on simplifying our operations to reduce complexity.”

Expressing gratitude to Natura &Co investors holding ADRs (American Depositary Receipts), Barbosa looks forward to welcoming many of them as shareholders on the B3 market in Brazil. He reassured that the company would maintain high disclosure standards through its listing in Brazil.

Over the past year, Natura &Co has faced financial challenges, reporting increased revenues despite setbacks from its more international labels, including The Body Shop and Aesop. As part of its strategic review, the group chose to sell both brands, reinforcing efforts to realign its operations.